Tare da taron shekara-shekara na 32nd na shekara-shekara na Ƙungiyar Urology (CUA) da za a gudanar a Dalian, na sake farawa, na sake duba ilimin da na baya na urological endoscopy. A cikin duk shekarun da na yi na endoscopy, ban taɓa ganin sashe ɗaya yana ba da nau'ikan nau'ikan endoscopes irin wannan ba, gami da na gani, lantarki, da ƙayyadaddun bayanai daban-daban. Bugu da ƙari, endoscopes na urological suna haɓaka da sauri, kuma a cikin gida, ana ba su sunaye masu ƙarfi kamar "cannonscope" da "ƙaddarar jigilar jirgin sama." Kwarewata ta farko da su tana da ban mamaki. A baya na tattara jerin bayyanuwa da samfuran masu sassauƙa da tsattsauran ra'ayi, wanda ke aiki azaman ƙwarewar koyo mai mahimmanci ga aikina.
Kwanan nan, ina koyon ilimin urological endoscopy tare da tunanin tushen sifili. Zan rubuta shi gwargwadon wurin da cutar ta kasance. Kafin koyo, zan fara fahimtar wasu mahimman bayanai.
Bayanai da adadin tiyata da ake buƙata don wasu yanayin urological
Urology yanzu ya kasu kashi kashi na fitsari na sama (koda da ureters), ƙananan urinary fili (bladder da prostate), da kuma andrology. Bugu da ƙari, tare da yawan tsufa, ana sa ran kamuwa da cututtukan urological zai tashi. Tushen bayanai: Wani bincike da aka buga a cikin Rahoton Kimiyya ta ƙungiyar Urology na Asibitin Haɗin Kan Farko na Jami'ar Soochow sun gudanar da cikakken bincike na farko game da nauyin duniya na BPH (mummunan cutar hawan jini) daga 1990 zuwa 2021 dangane da bayanan GBD 2021. Wani bincike da aka gudanar ya tabbatar da cewa kashi 61 cikin 100 na karuwar al'amura a duniya ya faru ne saboda yawan tsufa, kashi 29% zuwa karuwar yawan jama'a, da kuma kashi 10% zuwa canje-canjen annoba.
Ya zuwa karshen shekarar 2024, yawan mutanen kasar Sin masu shekaru 60 zuwa sama sun kai miliyan 310.31 (kimanin miliyan 310), wanda ya kai kashi 22.0% na yawan al'ummar kasar; A cikin su, yawan mutanen da ke da shekaru 65 zuwa sama sun kai miliyan 220.23 (kimanin miliyan 220), wanda ya kai kashi 15.6% na yawan jama'a.
Ciwon daji na Prostate (CA): Matsayi na farko a cikin cututtukan daji na urinary fili, tare da adadin abin da ya faru na 13.42 a cikin mutane 100,000. Dangane da birni mai yawan jama'a miliyan 5, ana samun sabbin maganganu 671 a shekara. Dangane da bita na 2025 "Tsarin Ciwon Cutar Ciwon Cutar Prostate, Halayen Halittu, da Jagoran Gaba don Ingantacciyar Gudanarwa a China," kusan kashi 54% na marasa lafiya a cikin ƙasata suna da metastases mai nisa a farkon ganewar asali. Saboda haka, adadin marasa lafiya da alamun tiyata kusan 671 * 0.46 = 308.
Ciwon daji na mafitsara: Adadin abin da ke faruwa shine 9.29 a cikin mutane 100,000, tare da sabon adadin shekara-shekara na kusan 465 a cikin birni mai yawan jama'a miliyan 5. Dangane da bayanan kan layi, ana ɗaukar ƙimar 75% NMIBC (Tis, Ta, T1), adadin sabbin lokuta na shekara-shekara tare da alamun tiyata shine 348. Ciwon daji na koda na Laparoscopic: Yawan abin da ya faru shine 7.37 a cikin mutane 100,000, tare da sabon yanayin shekara na kusan 368 a cikin birni mai yawan jama'a miliyan 5. Bisa ga halaye na pathological na "Nazarin Shekaru Goma game da Daidaitawa tsakanin Hanyoyin tiyata da Halayen Clinicopathological na Renal Cell Carcinoma" wanda Asibitin Farko na Jami'ar Peking ya buga, matakin pT1 ya kai 79.6%, wanda ya haifar da kimanin alamar tiyata na kimanin 293. Laparoscopic benign on the above hyperplasia prostatic data: 2024, za a sami mutane miliyan 310.31 a cikin ƙasata masu shekaru 60 zuwa sama, wanda ke da kashi 22.03% na yawan jama'a, wanda kusan kashi 48.73% maza ne (ku zo, maza, ba ku daɗe kamar mata). Abubuwan da ke faruwa na BPH a cikin waɗanda ke da shekaru 60 zuwa sama shine 50%, wanda 10% na buƙatar tiyata. Adadin mutanen da suke buƙatar maganin BPH a cikin birni mai yawan jama'a miliyan 5 shine: miliyan 5 * 22.03% * 48.73% * 50% * 10% ≈ 26,838 mutane, wanda yayi yawa sosai.
Duwatsun fitsari: Babu bayanan hukuma da aka samu. Dangane da adadin abin da ya faru na 5%, 25% na buƙatar magani na tiyata. A cikin birni mai yawan jama'a miliyan 5, abin da ke faruwa a shekara da magani ya kai kusan 62,500, wanda ya yi yawa. Tabbas, wannan shine mafi girman iyaka. Extracorporeal lithotripsy, ureteroscopic Laser lithotripsy, da percutaneous nephrolithotomy tare da pneumatic (laser) lithotripsy ana amfani dashi.
Daga sama zuwa kasa ta wurin wurin jiki
Percutaneous nephrolithotomy
Percutaneous nephrolithotomy (PCNL) hanya ce mai ƙarancin ɓarna wacce ke haifar da tashar ta cikin fata don magance tsakuwar koda ko raunuka. Ana amfani da shi da farko don magance manyan (> 2 cm) ko hadadden duwatsun koda. Babban fa'idodinsa sun ta'allaka ne a cikin ƙaramin rauni, saurin farfadowa, da ƙimar tsaftar dutse. Nephroscopes suna ƙara ƙarami a diamita, tare da daidaitattun tashoshi (24-30 Fr), microchannels (16-22 Fr), da tashoshi na ultrafine (<16 Fr). Na'urorin lithotripsy mai siffar allura tare da diamita a kusa da 1.4 mm yanzu ana samun su. Percutaneous nephrolithotomy daidaitaccen kayan aiki ne a cibiyoyin lithotripsy na urological.
The percutaneous nephroscope yana da filin kallo na 12°, elliptical sheath, waje diamita na 8.5 Fr/12 Fr, ingantaccen aiki tsawon kusan 250 mm, da kuma tashar aiki na kusan 6 Fr.
Mu, Jiangxi Zhuoruihua Medical Instrument Co., Ltd., wani manufacturer ne a kasar Sin ƙware a cikin endoscopic consumables, sun hada da GI line kamar biopsy forceps, hemoclip, polyp tarkon, sclerotherapy allura, fesa catheter, cytology goge, guidewire, dutse maido da dutse kwando, hanci biliary kwandon, hanci biliary da dai sauransu. ERCP. Kuma Layin Urology, kamarKumburin shiga urethra tare da tsotsakumaurethra samun kumfa,Kwandon Maido Dutsen fitsari mai zubarwa, kumaHanyar urologyda dai sauransu.
Samfuran mu suna da takardar shedar CE, kuma tsire-tsire namu suna da takaddun ISO. An fitar da kayanmu zuwa Turai, Arewacin Amurka, Gabas ta Tsakiya da wani yanki na Asiya, kuma suna samun abokin ciniki yabo da yabo!
Lokacin aikawa: Satumba-22-2025